About Mylan



On June 15, 2016, Renaissance Holdings completed the sale of its non-sterile, topicals-focused specialty and generics business, which includes Prestium Pharma, to Mylan. A global pharmaceutical company committed to setting new standards in healthcare, Mylan’s mission is to provide the world’s 7 billion people access to high quality medicine. Learn more about Mylan.